Diversity in autoimmune blistering disease clinical trials: a systematic review

Connor Cole¹, Roger Haber¹, Kyle T Amber^{2

3}

Affiliations

¹ Department of Dermatology, University of Illinois Health, Chicago, IL, USA.
² Division of Dermatology, Rush University Medical Center, Chicago, IL, USA.
³ Department of Internal Medicine, Rush University Medical Center, Chicago, IL, USA.

Comment

Connor Cole et al. Int J Dermatol. 2023 Oct.

. 2023 Oct;62(10):e561-e562.

doi: 10.1111/ijd.16680. Epub 2023 Apr 14.

Connor Cole¹, Roger Haber¹, Kyle T Amber^{2

3}

¹ Department of Dermatology, University of Illinois Health, Chicago, IL, USA.
² Division of Dermatology, Rush University Medical Center, Chicago, IL, USA.
³ Department of Internal Medicine, Rush University Medical Center, Chicago, IL, USA.

No abstract available

Comment on

Diversity in Dermatology Clinical Trials: A Systematic Review.
Charrow A, Xia FD, Joyce C, Mostaghimi A. Charrow A, et al. JAMA Dermatol. 2017 Feb 1;153(2):193-198. doi: 10.1001/jamadermatol.2016.4129. JAMA Dermatol. 2017. PMID: 28055072

1. McCarthy CR. Historical background of clinical trials involving women and minorities. Acad Med. 1994;69(9):695-8.
1. Hirano SA, Murray SB, Harvey VM. Reporting, representation, and subgroup analysis of race and ethnicity in published clinical trials of atopic dermatitis in the United States between 2000 and 2009. Pediatr Dermatol. 2012;29(6):749-55.
1. Charrow A, Xia FD, Joyce C, Mostaghimi A. Diversity in dermatology clinical trials: a systematic review. JAMA Dermatol. 2017;153(2):193-8.
1. Ajayi A, Sathi S, Petronic-Rosic V. Autoimmune bullous diseases in skin of color. Clin Dermatol. 2022;40:676-85. https://doi.org/10.1016/j.clindermatol.2022.07.002